Price T Rowe Associates Inc Ardelyx, Inc. Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Ardelyx, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 207,251 shares of ARDX stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

207,251

Previous 182,794 13.38%

Holding current value

$1.16 Million

Previous $898,000 9.47%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$3.28 - $5.51 $80,218 - $134,758	24,457 Added 13.38%	207,251 $813,000
Q1 2025 May 14, 2025	BUY	$4.91 - $6.36 $98,052 - $127,009	19,970 Added 12.26%	182,794 $898,000
Q4 2024 Feb 14, 2025	SELL	$4.49 - $6.85 $4.09 Million - $6.24 Million	-911,664 Reduced 84.85%	162,824 $826,000
Q3 2024 Nov 14, 2024	SELL	$5.28 - $7.57 $3.4 Million - $4.88 Million	-644,583 Reduced 37.5%	1,074,488 $7.41 Million
Q2 2024 Aug 14, 2024	SELL	$5.89 - $9.31 $12.9 Million - $20.4 Million	-2,194,792 Reduced 56.08%	1,719,071 $12.7 Million
Q1 2024 May 15, 2024	BUY	$6.05 - $9.74 $9.59 Million - $15.4 Million	1,584,597 Added 68.03%	3,913,863 $28.6 Million
Q4 2023 Feb 14, 2024	BUY	$3.29 - $6.64 $1.96 Million - $3.96 Million	597,099 Added 34.47%	2,329,266 $14.4 Million
Q3 2023 Nov 14, 2023	SELL	$3.3 - $4.83 $136,603 - $199,937	-41,395 Reduced 2.33%	1,732,167 $7.07 Million
Q2 2023 Aug 14, 2023	SELL	$3.23 - $4.95 $2.55 Million - $3.9 Million	-788,234 Reduced 30.77%	1,773,562 $6.01 Million
Q1 2023 May 15, 2023	BUY	$2.68 - $4.79 $711,191 - $1.27 Million	265,370 Added 11.56%	2,561,796 $12.3 Million
Q4 2022 Feb 14, 2023	BUY	$1.22 - $2.85 $2.8 Million - $6.54 Million	2,296,426 New	2,296,426 $6.55 Million
Q3 2021 Nov 15, 2021	SELL	$1.27 - $8.17 $3.03 Million - $19.5 Million	-2,385,162 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.55 - $8.98 $550,730 - $755,047	-84,081 Reduced 3.41%	2,385,162 $18.1 Million
Q1 2021 May 17, 2021	SELL	$6.1 - $7.69 $187,099 - $235,867	-30,672 Reduced 1.23%	2,469,243 $16.3 Million
Q4 2020 Feb 16, 2021	BUY	$5.05 - $7.1 $12.6 Million - $17.7 Million	2,499,915 New	2,499,915 $16.2 Million

Others Institutions Holding ARDX

# of Institutions

225

Shares Held

167M

Call Options Held

551K

Put Options Held

1.67M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $866M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Ardelyx, Inc. Transaction History